Article
The Impact of Systemic Lupus Erythematosus on the Clinical Phenotype of Antiphospholipid Antibody-Positive Patients: Results From the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Clinical Database and Repository.
Arthritis care & research - 1 Jan 2019
Unlu Ozan, Erkan Doruk, Barbhaiya Medha, Andrade Danieli, Nascimento Iana, Rosa Renata, Banzato Alessandra, Pengo Vittorio, Ugarte Amaia, Gerosa Maria, Ji Lanlan, Efthymiou Maria, Branch D Ware, de Jesus Guilherme Ramires, Tincani Angela, Belmont H Michael, Fortin Paul R, Petri Michelle, Rodriguez Esther, Pons-Estel Guillermo J, Knight Jason S, Atsumi Tatsuya, Willis Rohan, Zuily Stephane, Tektonidou Maria G
Abstract excerpt
OBJECTIVE: Although systemic lupus erythematosus (SLE) is the most common autoimmune disease associated with antiphospholipid antibodies (aPL), limited data exist regarding the impact of SLE on the clinical phenotype of aPL-positive patients. The primary objective of this study was to compare the clinical, laboratory, and treatment characteristics of aPL-positive patients with SLE with those of aPL-positive...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
